Back to Pulmonology
Pulmonologyv2018Evidence-Based

Estimated/Expected Peak Expiratory Flow (Peak Flow)

Estimates expected peak expiratory flow rate and quantifies asthma exacerbation severity based on age, height, race, and sex.

Clinical Input Parameters

years
Range: 5 — 80 years
cm
Range: 100 — 220 cm
L/min
Range: 50 — 800 L/min
Clinical Assessment
Awaiting Parameters
peak flow results
—L/min
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Estimated/Expected Peak Expiratory Flow (Peak Flow) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pulmonology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Variable formulas based on age and ethnicity: Ages 5-7 and 8-17 non-Caucasian: PEFR = [(Height, cm - 100) × 5] + 100; Adults 18-80 non-Caucasian: Male PEFR = {[(Height, m × 5.48) + 1.58] - [Age × 0.041]} × 60, Female PEFR = {[(Height, m × 3.72) + 2.24] - [Age × 0.03]} × 60; Caucasian/African American/Mexican American: Hankinson 1999 NHANES III equations

Clinical Pearls & Practice Notes

  • Formulas vary by age group and race/ethnicity
  • Height and sex are most strongly correlated with peak flow
  • Not a standalone diagnostic tool - must be combined with clinical assessment
  • Green zone: ≥80% of expected (good control)
  • Yellow zone: 50-79% of expected (caution, may need treatment adjustment)
  • Red zone: <50% of expected (emergency, seek immediate medical attention)
  • Peak flow variability >20% may suggest asthma diagnosis
  • Regular monitoring helps assess treatment effectiveness
  • Useful for patients without known baseline peak flow
  • Most accurate when compared to patient's personal best value
  • Environmental factors and technique can affect measurements
  • Consider diurnal variation in peak flow measurements

Evidence & Literature Citations

  1. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999 Jan;159(1):179-87. doi: 10.1164/ajrccm.159.1.9712108.
  2. Nunn AJ, Gregg I. New regression equations for predicting peak expiratory flow in adults. BMJ. 1989 Apr 22;298(6680):1068-70. doi: 10.1136/bmj.298.6680.1068.
  3. Godfrey S, Kamburoff PL, Nairn JR. Spirometry, lung volumes and airway resistance in normal children aged 5 to 18 years. Br J Dis Chest. 1970 Jan;64(1):15-24. doi: 10.1016/s0007-0971(70)80045-0.
  4. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. Available from: www.ginasthma.org

Score Interpretation Ranges

Normal≤ pts

Good control

Caution≤ pts

Reduced lung function

Emergency≤ pts

Severe obstruction

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.